Repaglinide is used for: Type 2 DM.
Recorded in the NepalDoc medicine catalog for Repaglinide.
Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitation of Use: Not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
From the U.S. FDA-approved label for Repaglinide. Full label: DailyMed.
Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitation of Use: Not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
From the U.S. FDA-approved label for Repaglinide. Full label: DailyMed.
The recommended starting dose is 0.5 mg orally before each meal if HbA1c is less than 8%; and 1 or 2 mg orally before each meal if HbA1c is 8% or greater. The recommended dose range is 0.5 mg to 4 mg before meals, with a maximum daily dose of 16 mg. The patient’s dose should be doubled up to 4 mg with each meal until satisfactory glycemic control is achieved.
Directions from the U.S. FDA-approved label for Repaglinide — your doctor or pharmacist may advise differently.
Repaglinide tablets are contraindicated in patients with: Concomitant use of gemfibrozil Known hypersensitivity to repaglinide or any inactive ingredients Concomitant use with gemfibrozil Known hypersensitivity to repaglinide or any inactive ingredients
Excerpt from the U.S. FDA-approved label for Repaglinide. Talk to a pharmacist or doctor before use.
Hypoglycemia: Repaglinide may cause hypoglycemia. Skip the scheduled dose of repaglinide if a meal is skipped to reduce the risk of hypoglycemia. Reduce the dose of repaglinide if hypoglycemia occurs. Serious Cardiovascular Adverse Reactions with Concomitant NPH-insulin: Repaglinide is not indicated for use in combination with NPH-insulin. Macrovascular outcomes: There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with repaglinide. 5.1 Hypoglycemia All glinides, including repaglinide, can cause hypoglycemia.
Warnings and precautions excerpt from the U.S. FDA-approved label for Repaglinide — not a complete list. Talk to a pharmacist or doctor before use.
The following serious adverse reaction is also described elsewhere in the labeling: Hypoglycemia The most common adverse reactions (5% or greater incidence) among patients treated with repaglinide were: hypoglycemia, upper respiratory infection, headache, sinusitis, arthralgia, nausea, diarrhea, and back pain. To report SUSPECTED ADVERSE REACTIONS, contact Aurobindo Pharma USA, Inc.
Excerpt from the U.S. FDA-approved label for Repaglinide — not a complete list. Talk to a pharmacist or doctor about side effects.
12 brands · 4 makers in the NepalDoc catalog — see the full Repaglinide guide →
Store at 20° to 25°C (68° to 77°F). Protect from moisture. Keep bottles tightly closed.
Storage information from the U.S. FDA-approved label for Repaglinide.
What is Eurepa?
Eurepa 1mg Tablet is a Repaglinide medicine made by Torrent Pharmaceuticals Ltd. It comes as 1mg Tablet.
What is Eurepa used for?
Repaglinide is used for Type 2 DM.
What is the generic name of Eurepa?
The generic name of Eurepa is Repaglinide.
Which brands of Repaglinide are available in Nepal?
12 brands of Repaglinide are listed in the NepalDoc catalog, from 4 makers — including Eurepa 2mg Tablet, Eurepa 0.5mg Tablet, Novonorm 0.5 Tablet, Novonorm 1 Tablet, Novonorm 2 Tablet, Premil 1mg Tablet.
What are the side effects of Repaglinide?
The following serious adverse reaction is also described elsewhere in the labeling: Hypoglycemia The most common adverse reactions (5% or greater incidence) among patients treated with repaglinide were: hypoglycemia, upper respiratory infection, headache, sinusitis, arthralgia, nausea, diarrhea, and back pain.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
